Hemington Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $529K | Buy |
2,854
+136
| +5% | +$25.2K | 0.08% | 76 |
|
|
2025
Q1 | $569K | Buy |
2,718
+182
| +7% | +$38.1K | 0.09% | 69 |
|
|
2024
Q4 | $450K | Buy |
2,536
+150
| +6% | +$26.6K | 0.11% | 79 |
|
|
2024
Q3 | $486K | Sell |
2,386
-105
| -4% | -$21.4K | 0.13% | 71 |
|
|
2024
Q2 | $427K | Buy |
2,491
+105
| +4% | +$18K | 0.14% | 78 |
|
|
2024
Q1 | $435K | Sell |
2,386
-82
| -3% | -$15K | 0.16% | 79 |
|
|
2023
Q4 | $382K | Buy |
2,468
+220
| +10% | +$34.1K | 0.15% | 78 |
|
|
2023
Q3 | $335K | Sell |
2,248
-200
| -8% | -$29.8K | 0.16% | 71 |
|
|
2023
Q2 | $329K | Sell |
2,448
-110
| -4% | -$14.8K | 0.13% | 74 |
|
|
2023
Q1 | $407K | Buy |
2,558
+37
| +1% | +$5.89K | 0.16% | 66 |
|
|
2022
Q4 | $407K | Buy |
2,521
+99
| +4% | +$16K | 0.17% | 62 |
|
|
2022
Q3 | $325K | Sell |
2,422
-6
| -0.2% | -$805 | 0.14% | 66 |
|
|
2022
Q2 | $372K | Buy |
2,428
+44
| +2% | +$6.74K | 0.15% | 69 |
|
|
2022
Q1 | $387K | Buy |
+2,384
| New | +$387K | 0.13% | 76 |
|
|
2021
Q4 | – | Sell |
-1,902
| Closed | -$205K | – | 82 |
|
|
2021
Q3 | $205K | Buy |
1,902
+38
| +2% | +$4.1K | 0.08% | 95 |
|
|
2021
Q2 | $210K | Buy |
+1,864
| New | +$210K | 0.09% | 86 |
|